Eyenovia, Inc. is a commercial-stage ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics based on its Optejet platform. It is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. We show 34 historical shares outstanding datapoints in our EYEN shares outstanding history coverage, used to compute EYEN market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing EYEN market cap history over the course of time is important for investors
interested in comparing EYEN's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of EYEN versus a peer is one thing; comparing
EYEN market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like EYEN can fluctuate over the course of history.
With this page we aim to empower investors researching EYEN by allowing them to research the EYEN market cap history. |
Free EYEN Email Alerts:
Video: The Importance of Market Cap
